Vol. 275, Issue 1, H213-H219, July 1998
Dynamics of spectral components of heart rate variability
during changes in autonomic balance
Michael V.
Højgaard1,2,
Niels-Henrik
Holstein-Rathlou2,
Erik
Agner1, and
Jørgen K.
Kanters1,2
1 Department of Internal
Medicine, Coronary Care Unit, Elsinore Hospital, DK-3400 Elsinore;
and 2 Department of Medical
Physiology, University of Copenhagen, DK-2200 Copenhagen,
Denmark
 |
ABSTRACT |
Frequency domain analysis of heart rate
variability (HRV) has been proposed as a semiquantitative method for
assessing activities in the autonomic nervous system. We examined
whether absolute powers, normalized powers, and the low
frequency-to-high frequency ratio (LF/HF) derived from the HRV power
spectrum could detect shifts in autonomic balance in a setting with low
sympathetic nervous tone. Healthy subjects were examined for 3 h in the
supine position during 1) control
conditions (n = 12),
2) acute
-blockade (n = 11), and
3) chronic
-blockade
(n = 10). Heart rate fell during the first 40 min of the control session (72 ± 2 to 64 ± 2 beats/min; P < 0.005) and was even
lower during acute and chronic
-blockade (56 ± 2 beats/min;
P < 0.005). The powers of all
spectral areas rose during the first 60 min in all three settings, more so with
-blockade (P < 0.05).
LF/HF was found to contain the same information as powers expressed in
normalized units. LF/HF detected the shift in autonomic balance induced
by
-blockade but not the change induced by supine position. In
conclusion, none of the investigated measures derived from power
spectral analysis comprehensively and consistently described the
changes in autonomic balance.
sympathetic and parasympathetic nervous activity; low
frequency-to-high frequency ratio and normalized units;
-blockade; posture; human subjects
 |
INTRODUCTION |
HEART RATE VARIABILITY (HRV) is a measure of the
variations in the interbeat intervals (R-R intervals) and is one of the
most powerful prognostic factors of mortality following myocardial infarction (16). For the most part, HRV is caused by
variations in input to the sinus node from the autonomic nervous
system. Multiple mechanisms cause the variation in autonomic activity, including respiration, baroreceptor reflexes, and inputs from higher
cerebral centers. Removal of direct autonomic nervous influence to the
sinus node nearly abolishes HRV, as seen after cardiac transplantation
(3, 23) or after combined
-adrenergic and parasympathetic blockade
(1, 21). The result is a highly regular ("metronome-like") heart
rate. The magnitude of HRV is probably more dependent on the modulation
of the firing frequency in the nerves than on the mean firing frequency
("nervous tone"), as suggested by Hedman et al. (12). Heart rate
depends on the sinus node's intrinsic rate and the integration of
sympathetic and parasympathetic nervous tone. The nature of this
integration is not completely understood, but heart rate and HRV are
often inversely related, indicating a relationship between nervous tone and the modulation of the firing frequency.
The variations in heart rate can be separated into different components
by use of spectral analysis. A high-frequency component (HF;
0.15-0.4 Hz) is generated by respiratory modulation of vagal nerve
activity (1, 17, 21). Slower fluctuations between 0.04 and 0.15 Hz
constitute the low-frequency component (LF), which is, to some extent,
generated by baroreceptor modulation of sympathetic and vagal nervous
tone; LF is believed by some investigators to be a marker of
sympathetic nervous tone (17). Variations at frequencies below 0.04 Hz
constitute the very low frequency (VLF) and ultralow frequency (ULF)
bands. The physiological origin of these very slow fluctuations is
still unsettled, but it has been suggested that variations in the
activity of the renin-angiotensin system (1) and thermoregulation (15)
are of importance. In addition, changes in physical activity may be
responsible for some of the HRV in the VLF and ULF bands (4).
It is controversial whether spectral analysis of HRV can be used to
determine either changes in the sympathovagal balance or the absolute
values of sympathetic and parasympathetic nervous modulation. Most
investigators agree that the power of the HF band reflects vagal
modulation, when expressed both in absolute power and in normalized
units. This view is supported by a study from Berger et al. (2), which
showed that modulation of sympathetic firing frequency in the HF area
is not reflected in the heart rate power spectrum because the
sympathetic receptors in the sinus node act as a low-pass filter with a
corner frequency of ~0.15 Hz. The controversial issue is whether the
LF band reflects sympathetic modulation and whether this modulation is
quantifiable by the amount of power in the band. In this connection,
the question of normalized units is central. When expressed in
normalized units, the LF band appears to reflect sympathetic modulation
in several settings, mainly involving sympathetic activation; this is
not the case when it is expressed in units of absolute power (18, 20).
Whether the low frequency-to-high frequency ratio (LF/HF) is a
comprehensive measure of autonomic balance is another controversial question, and the present paper examines this measure in settings with
low sympathetic nervous tone.
The effect of sympathetic blockade with
-blockers has also led to
conflicting results. In healthy subjects oral atenolol increased both
HRV and the powers in the LF and HF bands (6). In postinfarction
patients both atenolol and metoprolol increased HRV and the power in
the HF band (25). In contrast, oral acebutolol was reported to decrease
fluctuations in the LF band (10).
The purpose of the present study was to investigate the dynamic power
spectral changes of HRV in two settings with progressive lowering of
sympathetic nervous tone and rise in parasympathetic nervous tone. The
shift in autonomic balance was achieved by the supine position and by
-blockade with metoprolol. This was motivated by the fact that most
of the prior studies have been done in settings in which the
sympathetic nervous system was activated. If a comprehensive measure of
autonomic balance exists, it should also be useful in settings with
vagal predominance.
 |
METHODS |
Twelve health care workers (6 male and 6 female), aged between 25 and
38 yr, were included in the study. All of the subjects were healthy as
determined by their history and a brief examination; none received any
medication. The subjects gave informed consent, and the study was
approved by the local ethical review board.
All examinations took place in the morning in quiet surroundings. After
the subjects arrived, they sat quietly for 5 min and electrocardiogram
(ECG) electrodes were placed. They stood up, walked a few steps to a
couch, and assumed the supine position, and the ECG recording was
started immediately. The subjects were instructed to stay awake during
the entire recording period, and the supine position was maintained for
a minimum of 21/2 h. The subjects were examined during three
conditions: 1) a control period (n = 12);
2) acute
-blockade
[n = 11; metoprolol (Seloken;
Astra) was given at a rate of 0.9 mg/min iv for the first 20 min and then at 0.18 mg/min for the remainder of the period, ensuring a fairly
constant plasma concentration (22)]; and
3) chronic
-blockade
[n = 10; metoprolol (SeloZok;
Astra) was given for 3 wk in a dose of 100 mg once a day].
Initially, there was the same number of subjects in each group, but
because of a computer malfunction some data were lost. This did not
represent a selection of subjects and did not influence the result of
the study.
ECG recording.
Continuous ECG was recorded digitally using a Custo Med R6 ambulatory
ECG recorder (Custo Med) with a sampling rate of 500 Hz. After on-line
determination of the R-R intervals with an autocorrelation technique
for R wave detection, the segment of the digitally recorded ECG was
compressed and stored together with the R-R interval for later
retrieval. All R-R intervals were manually reviewed, and premature
beats and artifacts were removed. In the case of premature beats, the
R-R intervals both before and after the beat were removed. No subject
had >10 premature beats/h.
Spectral analysis.
For power spectral analysis, a fast Fourier transform with a square
window was used. The power spectrum was calculated as the square of the
absolute values of the corresponding Fourier transform. For assessments
of dynamic changes in HRV, power spectra were computed on series of 512 beats. Consecutive series were initiated at 10-min intervals, so the
starting points of the series were 0 min, 10 min, 20 min, and so forth.
The power spectra were corrected with respect to the mean heart rate in
the actual window, resulting in a frequency unit of equivalent Hertz
(eqHz). Because of the relatively short time series, no ULF band was
calculated and the VLF band was defined as the power at frequencies
<0.04 Hz (24).
Spectral powers were calculated as absolute powers, normalized units,
and the coefficient of component variance (CCV; Ref. 11). Normalized
units were calculated for the LF and the HF bands as
CCV
was calculated as the square root of power divided by the mean R-R
interval and expressed as a percentage. CCV reduces the correlation
between the mean R-R interval and spectral power that can be seen under
some circumstances (24).
Statistical analysis.
The distributions of spectral powers were skewed to the right and,
therefore, were transformed to their logarithms
(log10). For statistical
comparisons, heart rate and spectral powers were averaged over the nine
512-beat series in the interval from 60 min to 140 min. The resulting
values were compared with the values at 0 min using a two-tailed,
paired t-test. In addition, the values at 0 min and the mean from 60 min to 140 min were compared with corresponding values between sessions, also using a two-tailed, paired
t-test. A
P value of <0.05 was considered
statistically significant. Regression and correlation analyses were
done using the regression module in Statistica (StatSoft, Tulsa, OK).
Values are presented as means ± SE.
 |
RESULTS |
Normalization.
As demonstrated in Fig. 1, nearly perfect
linear relations exist between the normalized HF power
(HFnu) and 1/(1
LF/HF) and the normalized LF power
(LFnu) and 1/(1
HF/LF),
respectively. The regression lines are not significantly different from
the line of identity, and the correlation coefficients are close to 1 (r2 = 0.99 and
0.98, respectively). This supports the theoretical arguments, shown in
the APPENDIX, that lead to the
conclusion that LF/HF, LFnu, and
HFnu all contain the same
information. Because of this close relationship, only LF/HF will be
presented.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Relationship between transformed low frequency (LF)/high frequency (HF)
index and normalized HF area and normalized LF area. nu, Normalized
units.
|
|
Power spectral analysis.
Figure 2 shows the time course of heart
rate after the subjects were placed in the supine position during all
three experimental conditions. The initial heart rate
(t = 0 min) was significantly lower
during chronic
-blockade compared with both control and acute
-blockade (Table 1). Heart rate fell
significantly in all three cases and reached a stable value after ~40
min. Acute and chronic
-blockade resulted in similar heart rates
after 20 min, indicating that, at this point, the full
-blocking
effect was reached during intravenous administration. In both cases, the heart rate was significantly reduced compared with the control condition (Fig. 2 and Table 1).
Chronic
-blockade increased initial heart rate variability as
evidenced by an increase in the total power at
t = 0 min compared with the control
condition (Table 1 and Fig. 3). Although
the initial powers tended to be higher in all frequency domains (VLF, LF, and HF) during chronic
-blockade, it was only the value for the
HF power that was statistically significant (Table 1). This was also
true when the powers were expressed as CCV.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Dynamic power distribution over time for very low frequency (VLF) area
(A), LF area
(B), HF area
(C) and total power
(D) during the 3 recording days.
, Control; , acute -blockade; ×, chronic -blockade.
|
|
Lying down caused an increase in total power and in the powers of all
frequency domains (VLF, LF, and HF) in all three conditions. As seen in
Fig. 3, a steady state was reached after ~60 min, i.e., somewhat
later than for the heart rate. The steady-state levels were
significantly higher during chronic
-blockade compared with the
control condition, but when corrected for the lower heart rate, this
only reached statistical significance for the HF power. The same
pattern was evident during acute
-blockade, and there were no
significant differences between the steady-state values of the various
powers during acute and chronic
-blockade.
The supine position was not associated with a redistribution of the
initial powers in the HF and the LF bands, as evidenced by an unchanged
LF/HF (Table 1). In contrast,
-blockade was associated with a
significant decrease in LF/HF during acute
-blockade and a
persistence of the lower LF/HF during chronic
-blockade (Fig. 4 and Table
1).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Development in coefficient of component variance for HF area
(CCVHF;
A) and LF area
(CCVLF;
B) and LF/HF index
(C) during the 3 recording days.
, Control; , acute -blockade; ×, chronic
-blockade.
|
|
All frequency spectra at 0 and 60 min were manually reviewed to
determine the center frequency of the HF peak. In two cases, one during
acute
-blockade and one during chronic
-blockade, a distinct HF
peak could not be detected. The center frequencies (in Hz) of the HF
peak were 0.27 ± 0.01 at 0 min and 0.25 ± 0.01 at 60 min during
the control experiment (n = 12), 0.27 ± 0.02 at 0 min and 0.25 ± 0.02 at 60 min during acute
-blockade (n = 10), and 0.26 ± 0.01 at 0 min and 0.24 ± 0.01 at 60 min during chronic
-blockade (n = 9). Pooling the
three days revealed averaged center frequencies (in Hz) of 0.27 ± 0.01 at 0 min and 0.25 ± 0.01 at 60 min
(P < 0.01).
 |
DISCUSSION |
Previous studies have indicated that a shift in the autonomic balance
was associated with a redistribution of the power between the LF and
the HF bands, and it was suggested that normalized power units
(LFnu and
HFnu) or LF/HF were efficient
means for detecting shifts in autonomic balance (17, 24). This could not be confirmed in the present study. When the subjects were placed in
the supine position, autonomic balance was progressively altered, as
evidenced by the marked reduction in heart rate, which can only be
explained by a shift in the autonomic balance in favor of the
parasympathetic nervous system. Both during the control recording and
during the chronic
-blockade recording, HRV and LF and HF powers all
increased but LF/HF did not change significantly. This demonstrates
that the LF/HF index is not a consistent measure of autonomic balance
under these conditions.
Previous studies that observed a shift in LF and HF powers used
experimental protocols that led to increased sympathetic nervous tone
and decreased vagal tone (17, 18, 20). In these studies heart rate
increased, and this was associated with a large reduction in HF power
and no or only a small decrease in LF power and thus a rise in the
LF/HF index. These observations led to the suggestion that the LF/HF
index could be used as an indicator of autonomic balance. In the
present study, we failed to find any change in the LF/HF index when the
experimental subjects were placed in the supine position. There could
be several reasons for this discrepancy. The LF/HF index during the
control recording is of the same magnitude as the LF/HF index during
rest in the earlier studies (18, 20). It could therefore be argued that
the assumption of the supine position, before the start of the
recordings, had already caused a change in the autonomic balance
compared with the standing position. Although this may have occurred to
some extent, it is clear that a significant change in autonomic balance
takes place during the recording period, as evidenced by the
considerable decrease in heart rate.
A second possibility is that assumption of the supine position caused a
decrease in the respiratory frequency. If the respiratory frequency
decreases to values below ~9 breaths/min, part of this activity moves
into the LF area. This would increase LF power and decrease HF power
and thus could mask the change in LF/HF caused by changes in autonomic
balance. Although we did not measure respiratory frequency in the
experimental subjects, this possibility seems unlikely because the
change in the center frequency of the HF area was small. Previous
studies have shown that the center frequency of the HF area correlates
closely with the respiratory frequency (19). Thus it appears unlikely
that there should have been a major decrease in the respiratory
frequency in the supine position.
Most likely, the sympathetic activity is quite low at the start of the
recording period in the present study. A third reason for the apparent
discrepancy between this and the previous studies could therefore be
that "noise" and the increased low-frequency modulation caused by
increased vagal activity mask the expected decrease in the LF band.
However, despite these considerations, it is clear from the present
results that it is possible to have a marked change in the balance
between the tones of the sympathetic and parasympathetic nervous
systems without a change in the ratio or the distribution of the powers
in the LF and HF bands.
It was only when the positional change was combined with acute
-blockade that the expected shift in LF/HF was observed in the
present study. However, a closer inspection of the data reveals that
this was not caused by a change in the LF band but rather by changes in
the HF band. During acute
-blockade, the power in the LF band
followed virtually the same course as during the control experiment,
whereas the power in the HF band showed a greater increase. The
increased HF power was also present after chronic
-blockade with no
significant change in LF power. If sympathetic activity contributes to
the power in the LF band, but not in the HF band, it is difficult to
explain these findings as the result of sympathetic withdrawal. Rather,
it appears that
-blockade with metoprolol enhances vagal modulation,
preferentially at the respiratory frequency (the HF band). This could
be through a central effect, because metoprolol is lipid soluble and
therefore readily passes through the blood-brain barrier. However, a
similar observation was made with the water-soluble drug atenolol (6), which scarcely passes through the blood-brain barrier (9). This
observation makes it less likely that the effect is caused by a central
action of the drug. Because the sinus node, at least to some extent,
acts as a low-pass filter of vagal modulation (2), a second possibility
is that sympathetic activity influences the filtering characteristics
of the sinus node. Thus we speculate that acute
-blockade may lower
the time constant of the sinus node and thereby enhance vagally
mediated frequencies >0.15 Hz. Clearly, this speculation requires
experimental verification.
Interestingly, the complete effect of
-blockade on heart rate
appears to be achieved after only 20-30 min. During both acute and
chronic
-blockade, heart rate was similar at this point in time.
As is the case with many other indirect physiological measures, it
seems that there are limitations to the use of LF/HF as a marker of
autonomic balance. This is not surprising, considering that the
rationale for using LF/HF is that LF fluctuations are caused by the
combined action of the sympathetic and the vagal nerves, whereas HF
fluctuations are caused only by vagal activity. A priori, one would
therefore expect that LF/HF was of little use in detecting decreases in
sympathetic activity in settings in which the sympathetic tone is
already low. The present study confirms this expectation. Also, in
settings with high sympathetic tone but without specific enhancements
of LF fluctuations in the sympathetic nerves, one would not expect
LF/HF to be useful in assessing autonomic balance. This has recently
been confirmed in a study by Hoshikawa and Yamamoto (13). On the other
hand, it is well known that LF/HF can detect large, oppositely
directed, and preferably baroreceptor-mediated shifts in sympathetic
and vagal tone (20). However, as this and other studies have shown, there are limitations for its general use as a marker of
sympathetic-parasympathetic balance. Because it is impossible to
predict whether LF/HF will work as a marker for autonomic balance in a
given experimental or clinical situation, it is advisable always to
test its usefulness under the appropriate experimental or clinical
conditions.
The results of the present study show that it takes almost an hour to
achieve stationarity in the heart rate and HRV after a change from the
standing to the supine position. This is much longer than the
equilibration period normally used in studies that examine the effect
of positional changes on HRV. Because stationarity is a requirement in
spectral analysis, the slow rise in HRV calls for caution when
examining power spectra from short-term HRV analysis. It also stresses
the importance of stating the conditions (time from lying down, length
of time series, etc.) under which an R-R time series has been obtained
so that results can be compared between laboratories.
Because it was outside the scope of the present study to investigate
the physiological mechanisms that underlie the changes in heart rate
and HRV, no hemodynamic variables besides heart rate were measured.
There can be little doubt, however, that the changes in hemodynamics
associated with achieving the supine position involve a movement of
blood to the central veins, leading to an increased venous return to
the heart. This triggers low-pressure baroreceptors. Distension of the
ventricles also leads to an increased cardiac output by the
Frank-Starling mechanism, which in turn triggers arterial
baroreceptors. Both mechanisms will lead to lower sympathetic activity
and cause vagal activation.
On longer timescales possible mechanisms that could influence the HRV
would be blood pressure-regulating systems working on relevant
timescales (<1 h), e.g., the renin-angiotensin system, vasopressin,
or the capillary fluid shift mechanism. Vasopressin modifies the
baroreceptor response, but there are no studies investigating its
effect on HRV (8). The effect of the renin-angiotensin system on HRV is
not well understood, either. In dogs, angiotensin-converting enzyme
inhibition (ACE-I) increased VLF power (1); in humans, the results with
ACE-I have been conflicting. Enalapril had no influence on HRV in
healthy subjects (14), but HRV increased during treatment of patients
with congestive heart failure (26). In patients with congestive heart
failure, zofenopril increased total power with 50% and HF power with
200%, suggesting a major role of the renin-angiotensin system in
regulating HRV (5). On timescales of minutes to one hour, these
hormones could influence HRV through modulation of the baroreceptor
response. The fluid shift mechanism causes a net distribution of fluid
into the vessels in the supine position, and the effect on HRV would be
mediated through baroreceptor responses.
Several normalization procedures have been suggested in earlier studies
(11, 20). Normalization of spectral powers by the method of coefficient
of variance is done to minimize the dependence on heart rate. In the
present study, the result from this procedure was no different from
what was seen by examining absolute powers. Normalized units were
implemented as a means of explaining power spectral changes in relation
to known physiological changes. As seen in the
APPENDIX, theoretically, the
normalized powers contain no additional information compared with
LF/HF. This is also confirmed experimentally, because an almost perfect correlation exists between the transformed LF/HF and the normalized powers. The only parameter that could confound the transformation of
LF/HF to normalized units is the power above 0.4 Hz. Thus, in
conditions with very low HRV, there could be a decreased correlation between the normalized powers and the transformed LF/HF because the
noise in the area above 0.4 Hz will have relatively more weight in the
power spectrum. However, the power above 0.4 Hz has no known relation
to changes in the sympathovagal balance.
The present study demonstrates that LF/HF is not a comprehensive and
consistent measure of autonomic balance. In a setting with low
sympathetic tone and weak modulation by the sympathetic nervous system,
LF/HF fails to detect shifts in autonomic balance. Normalized powers
describe a balance rather than a modulation from individual limbs of
the autonomic nervous system, and they reveal no additional information
compared with the LF/HF index. Lying down leads, in itself, to a
progressive increase in total power and the powers of the VLF, LF and
HF bands, an increase that continues for 1 h before a plateau phase is
reached. Metoprolol increases total power and HF power and enhances
vagal modulation at the respiratory frequency.
 |
APPENDIX |
Because TP is the total power from 0 to 0.5 Hz, it can be seen that
|
(A1)
|
where
P>0.4Hz is the power in the area
above 0.4 Hz. Because HRV resembles fractal Brownian motion (a 1/f
process), the amount of power above 0.4 Hz is negligible. Thus,
P>0.4Hz
0
|
(A2)
|
|
(A3)
|
By
dividing LF into the nominator and denominator in Eq. A2 and dividing HF into the nominator and denominator
in Eq. A3 we get
|
(A4)
|
which
leads to the conclusion that normalized power is just a simple monotone
transformation of LF/HF and contains no additional information compared
with LF/HF. Setting f(x) = 1/(1 + x), we have
|
(A5)
|
Because
f(x) is a monotonically decreasing
function of x (for
x > 0), it follows that if
LFnu increases there is a decrease in HFnu and vice versa. Thus the
use of normalized units could be replaced by LF/HF.
 |
ACKNOWLEDGEMENTS |
The present study was supported by grants from the University of
Copenhagen School of Medicine, the Danish Heart Foundation, the Medical
Foundation for North Zealand, Bornholm, and West Seeland Counties, The
Foundation of 1870, and the Danish Medical Research Council.
 |
FOOTNOTES |
Address for reprint requests: M. V. Højgaard, Dept. of Medical
Physiology 10.5, Univ. of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen
N, Denmark.
Received 11 August 1997; accepted in final form 9 April 1998.
 |
REFERENCES |
1.
Akselrod, S.,
D. Gordon,
F. A. Ubel,
D. C. Shannon,
A. C. Berger,
and
R. J. Cohen.
Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.
Science
213:
220-222,
1981[Abstract/Free Full Text].
2.
Berger, R. D.,
J. P. Saul,
and
R. J. Cohen.
Transfer function analysis of autonomic regulation. I. Canine atrial rate response.
Am. J. Physiol.
256 (Heart Circ. Physiol. 25):
H142-H152,
1989[Abstract/Free Full Text].
3.
Bernardi, L.,
F. Keller,
M. Sanders,
P. S. Reddy,
B. Griffith,
F. Meno,
and
M. R. Pinsky.
Respiratory sinus arrhythmia in the denervated human heart.
J. Appl. Physiol.
67:
1447-1455,
1989[Abstract/Free Full Text].
4.
Bernardi, L.,
F. Valle,
M. Coco,
A. Calciati,
and
P. Sleight.
Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms.
Cardiovasc. Res.
32:
234-237,
1996[Abstract/Free Full Text].
5.
Binkley, P. F.,
G. J. Haas,
R. C. Starling,
E. Nunziata,
P. A. Hatton,
C. V. Leier,
and
R. J. Cody.
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.
J. Am. Coll. Cardiol.
21:
655-661,
1993[Abstract].
6.
Cook, J. R.,
J. T. Bigger, Jr.,
R. E. Kleiger,
J. L. Fleiss,
R. C. Steinman,
and
L. M. Rolnitzky.
Effect of atenolol and diltiazem on heart period variability in normal persons.
J. Am. Coll. Cardiol.
17:
480-484,
1991[Abstract].
7.
Coumel, P.,
P. Maison-Blanche,
and
D. Catuli.
Heart rate and heart rate variability.
In: Heart Rate Variability, edited by M. Malik,
and A. J. Camm. Armonk, NY: Futura, 1995, p. 207-221.
8.
Cowley, A. W., Jr.,
and
J. F. Liard.
Vasopressin and arterial pressure regulation.
Hypertension
11:
I25-I32,
1988.
9.
Cruickshank, J. M., G. Neil-Dwyer, M. M. Cameron, and J. McAinsh. Beta-adrenoreceptor-blocking agents and
the blood-brain barrier. Clin. Sci.
(Colch.) 59, Suppl. 6:
453S-455S, 1980.
10.
Girard, A.,
B. Meilhac,
C. Mounier-Vehier,
and
J. L. Elghozi.
Effects of beta-adrenergic blockade on short-term variability of blood pressure and heart rate in essential hypertension.
Clin. Exp. Hypertens.
17:
15-27,
1995.
11.
Hayano, J.,
Y. Sakakibara,
M. Yamada,
T. Kamiya,
T. Fujinami,
K. Yokoyama,
Y. Watanabe,
and
K. Takata.
Diurnal variations in vagal and sympathetic cardiac control.
Am. J. Physiol.
258 (Heart Circ. Physiol. 27):
H642-H646,
1990[Abstract/Free Full Text].
12.
Hedman, A. E.,
J. E. Hartikainen,
K. U. Tahvanainen,
and
M. O. Hakumaki.
The high frequency component of heart rate variability reflects cardiac parasympathetic modulation rather than parasympathetic "tone."
Acta Physiol. Scand.
155:
267-273,
1995[Medline].
13.
Hoshikawa, Y.,
and
Y. Yamamoto.
Effects of Stroop color-word conflict test on the autonomic nervous system responses.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1113-H1121,
1997[Abstract/Free Full Text].
14.
Kaufman, E. S.,
M. S. Bosner,
J. T. Bigger, Jr.,
P. K. Stein,
R. E. Kleiger,
L. M. Rolnitzky,
R. C. Steinman,
and
J. L. Fleiss.
Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects.
Am. J. Cardiol.
72:
95-99,
1993[Medline].
15.
Kitney, R. I.,
and
O. Rompelman.
Analysis of the interaction of the human blood pressure and thermal system.
In: Biomedical Computing, edited by W. J. Perkins. London, UK: Pitman Medical, 1977, p. 49-54.
16.
Kleiger, R. E.,
J. P. Miller,
J. T. Bigger, Jr.,
and
A. J. Moss.
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.
Am. J. Cardiol.
59:
256-262,
1987[Medline].
17.
Malliani, A.,
M. Pagani,
F. Lombardi,
and
S. Cerutti.
Cardiovascular neural regulation explored in the frequency domain.
Circulation
84:
482-492,
1991[Abstract/Free Full Text].
18.
Montano, N.,
T. G. Ruscone,
A. Porta,
F. Lombardi,
M. Pagani,
and
A. Malliani.
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.
Circulation
90:
1826-1831,
1994[Abstract/Free Full Text].
19.
Novak, V.,
P. Novak,
J. de Champlain,
A. R. Le Blanc,
R. Martin,
and
R. Nadeau.
Influence of respiration on heart rate and blood pressure fluctuations.
J. Appl. Physiol.
74:
617-626,
1993[Abstract/Free Full Text].
20.
Pagani, M.,
F. Lombardi,
S. Guzzetti,
O. Rimoldi,
R. Furlan,
P. Pizzinelli,
G. Sandrone,
G. Malfatto,
S. Dell'Orto,
E. Piccaluga,
M. Turiel,
G. Baselli,
S. Cerutti,
and
A. Malliani.
Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog.
Circ. Res.
59:
178-193,
1986[Abstract/Free Full Text].
21.
Pomeranz, B.,
R. J. B. Macaulay,
M. A. Caudill,
I. Kutz,
D. Adam,
D. Gordon,
K. M. Kilborn,
A. C. Barger,
D. C. Shannon,
R. J. Cohen,
and
H. Benson.
Assessment of autonomic function in humans by heart rate spectral analysis.
Am. J. Physiol.
248 (Heart Circ. Physiol. 17):
H151-H153,
1985[Abstract/Free Full Text].
22.
Regardh, C. G.,
G. Johnsson,
L. Jordo,
P. Lungborg,
B. A. Persson,
and
O. Ronn.
Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
J. Cardiovasc. Pharmacol.
2:
715-723,
1980[Medline].
23.
Sands, K. E.,
M. L. Appel,
L. S. Lilly,
F. J. Schoen,
G. H. J. Mudge,
R. J. Cohen,
and
G. H. Mudge, Jr.
Power spectrum analysis of heart rate variability in human cardiac transplant recipients.
Circulation
79:
76-82,
1989[Abstract/Free Full Text].
24.
Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology.
Heart rate variability
standards of measurement, physiological interpretation, and clinical use.
Eur. Heart J.
17:
354-381,
1996[Free Full Text].
25.
Tuininga, Y. S.,
H. J. Crijns,
J. Brouwer,
M. P. van den Berg,
A. J. Man in't Veld,
G. Mulder,
and
K. I. Lie.
Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
Circulation
92:
3415-3423,
1995[Abstract/Free Full Text].
26.
Zhang, Y. H.,
Y. C. Song,
J. Zhu,
T. H. Hu,
and
L. L. Wan.
Effects of enalapril on heart rate variability in patients with congestive heart failure.
Am. J. Cardiol.
76:
1045-1048,
1995[Medline].
Am J Physiol Heart Circ Physiol 275(1):H213-H219
0002-9513/98 $5.00
Copyright © 1998 the American Physiological Society